Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique

Journal of Microencapsulation

Volumn 28, Issue 6, 2011, Pages 537-548

  Chirio, Daniela ^a   Gallarate, Marina ^a   Peira, Elena ^a   Battaglia, Luigi ^a   Serpe, Loredana ^a   Trotta, Michele ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Coacervation; Curcumin; Fatty acids; SLN

Indexed keywords

BEHENIC ACID; CHITOSAN; CURCUMIN; FATTY ACID; MYRISTIC ACID; NONIONIC SURFACTANT; PALMITIC ACID; POLYMER; SODIUM; SOLID LIPID NANOPARTICLE; STEARIC ACID;

ARTICLE; CANCER CELL; CELL VIABILITY; COACERVATION; COLON CANCER; DRUG FORMULATION; ENCAPSULATION; HUMAN; HUMAN CELL; HYDROLYSIS; MOLECULAR WEIGHT; PRECIPITATION; SURFACE TENSION; ULTRAVIOLET SPECTROSCOPY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMA; CURCUMIN; DRUG CARRIERS; FATTY ACIDS; HUMANS; NANOPARTICLES; NEOPLASMS;

EID: 80051769289     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2011.590615     Document Type: Article

References (31)

1. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res, 2003;23:363-98. (Pubitemid 36361976)
2. Battaglia L, Gallarate M, Cavalli R, Trotta M. Solid lipid nanoparticles produced through a coacervation method. J Microencapsulation, 2010;27:78-85.
3. Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des, 2002;8:1695-706. (Pubitemid 34846196)
4. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res, 2001;21:2895-900.
5. Chirio D, Gallarate M, Trotta M, Carlotti ME, Calcio Gaudino E, Cravotto G. Influence of a-and y-cyclodextrin lipophilic derivatives on curcumin-loaded SLN. J Incl Phenom Macrocycl Chem, 2009;65:391-402.
6. Freitas C, Müller RH. Correlation between longterm stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm, 1999;47:125-32. (Pubitemid 29185115)
7. Goto M, Asada E. The crystal structure of the B-form of stearic acid. Bull Chem Soc Jpn, 1978;51:2456-9.
8. Hong S, Albu R, Labbe C, Lasuye T, Stasik B, Riess G. Preparation and characterisation of colloidal dispersions of vinyl alcohol-vinyl acetate copolymers: Application as stabilisers for vinyl chloride suspension polymerisation. Polym Int, 2006;55:1426-34. (Pubitemid 44823252)
9. Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLN). Biomaterials, 2003;24:1781-5. (Pubitemid 36184733)
10. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res, 1991;51:813-19.
11. Jaiswal AS, Marlow BP, Gupta N, Narayan S. Betacatenin-mediated trans-activation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene, 2002;21:8414-27. (Pubitemid 36061200)
12. Liu J, Gong T, Wang C, Zhong Z, Zhang Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles. Preparation and characterisation. Int J Pharm, 2007;340: 153-62. (Pubitemid 47044961)
13. Lin JK, Pan MH, Shiau SYL. Recent studies on the biofunctions and biotransformations of curcumin. Biofactors, 2000;13:153-8.
14. Lopez-Lazaro M. Anticancer and carcinogenic properties of curcumin: Considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res, 2008;52:S103-27.
15. Lopez-Lazaro M, Willmore E, Jobson A, Gilroy KL, Curtis H, Padget K, Austin CA. Curcumin induces high levels of topoisomerase I-and II-DNA complexes in K562 leukemia cells. J Nat Prod, 2007;70: 1884-8.
16. Mukerjee A, Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res, 2009;29:3867-75.
17. Nautiyal J, Banerjee S, Kanwar SS, Yu Y, Patel BB, Sarkar FH, Majumdar Adhip PN. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. Int J Cancer, 2011;128:951-61.
18. Pfeiffer E, Hohle S, Solyom A, Metzler M. Studies on the stability of turmeric constituents. J Food Eng, 2003;56:257-9. (Pubitemid 35384659)
19. Popa MI, Aelenei N, Popa VI, Andrei D. Study of the interactions between polyphenolic compounds and chitosan. React Funct Polym, 2000;45: 35-43.
20. Raghavan R, Burchett M, Loffredo D, Mulligan JA. Low-level (PPB) determination of cisplatin in cleaning validation (Rinse Water) samples. II. A high-performance liquid chromatographic method. Drug Dev Ind Pharmacy, 2000;6:429-40. (Pubitemid 30207715)
21. Schubert MA, Müller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parameters. Eur J Pharm Biopharm, 2003;55:125-31. (Pubitemid 36120504)
22. Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res, 2001;7:1894-900. (Pubitemid 32994823)
23. Siekmann B, Westesen K. Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids Surf B, 1994;3:159-75.
24. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Nat Acad Sci USA, 2000;97:4790-5. (Pubitemid 30238636)
25. Takahashi M, Uechi S, Takara K, Asikin Y, Wada K. Evaluation of an oral carrier system in rats: Bioavailability and antioxidant properties of lipo-some-encapsulated curcumin. J Agric Food Chem, 2009;57:9141-6.
26. Thangapazham RL, Sharma A, Maheshwari RK. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J, 2006;8:E443-9. (Pubitemid 44096605)
27. Tonnesen HH, Karlsen J, Van Henegouwen GB. Studies on curcumin and curcuminoids: VIII-photochemical stability of curcumin. Z Lebensm Unters Forsch, 1986;183:116-22.
28. Tønnesen HH, Másson M, Loftsson T. Studies of curcumin and curcumi-noids. Cyclodextrin complexation: Solubility, chemical and photochemical stability. Int J Pharm, 2002;244:127-35. (Pubitemid 35245453)
29. Van Erk MJ, Teuling E, Staal YC, Huybers S, Van Bladeren PJ, Aarts JM, Van Ommen B. Time-and dose-dependent effects of curcumin on gene expression in human colon cancer cells. J Carcinog, 2004;3:8-17.
30. Villegas I, Sánchez-Fidalgo S, Alarcón de la Lastra C. New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol Nutr Food Res, 2008;52:1040-61.
31. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal, 1997;15:1867-76.